Understanding Triple Negative Breast Cancer

Why is it crucial for patients to know their receptor status early in their care?

• To choose the right hospital for treatment

• To decide on the necessity of chemotherapy

• To determine the type of surgery needed

• To avoid radiation therapy

What makes triple negative breast cancer distinct from other types?

• It is sensitive to hormonal therapy

• It is more common in older women

• It grows slower than other cancers

• It lacks three specific receptors

What percentage of invasive breast cancers are triple negative?

• 35%

• 15%

• 5%

• 25%

What is the primary treatment for triple negative breast cancer?

• Radiation therapy

• Chemotherapy

• Hormonal therapy

• Surgery only

What is a potential advantage of receiving chemotherapy before surgery?

• It can shrink the tumor, allowing for less invasive surgery

• It is less expensive than post-surgery chemotherapy

• It eliminates the need for surgery

• It reduces the risk of cancer recurrence

What is a potential benefit of neoadjuvant chemotherapy?

• It can make tumors operable with less extensive surgery

• It is less effective than adjuvant chemotherapy

• It allows for immediate surgery

• It eliminates the need for genetic testing

How is the BRCA mutation related to triple negative breast cancer?

• It guarantees the development of breast cancer

• It is unrelated to breast cancer

• It only affects men

• It increases the risk of developing triple negative breast cancer

Which group is at a higher risk for triple negative breast cancer?

• Women with no family history of cancer

• Women over 70

• Men of any age

• African-American women

What should patients consider when deciding on genetic testing for the BRCA mutation?

• The hospital they are treated at

• The type of chemotherapy they will receive

• Their age and family history

• The cost of the test

Why are clinical trials important for triple negative breast cancer?

• They are only for patients who have not responded to other treatments

• They guarantee a cure for all participants

• They help discover new drugs with fewer side effects

• They provide free treatment to all patients